Eric L. Johnson MD North Dakota Diabetes

11/06/2025

What was the problem here? It’s common and I hear it a lot.

11/04/2025

November is Diabetes Awareness Month. I’ve had Type 1 diabetes for 36 years and it was a life changing diagnosis. Thanks to family, friends, and colleagues who have supported me along the way.

https://www.facebook.com/share/p/1BEzDbWRgP/?mibextid=wwXIfr

Join the fight to end diabetes and help spread awareness this with our free toolkit available at bit.ly/4ogc27c.

Show your support—drop a 💙 below if you’re joining us in the fight to end diabetes!

10/24/2025

Closed loop insulin delivery superior to standard care in pregnant patients with type 1 diabetes

This randomized clinical trial assesses the effect of a closed-loop insulin system on time spent in the pregnancy-specific glucose range among pregnant women with type 1 diabetes.

09/30/2025

Official announcement of ADA’s new journal, coming Feb 2026. I serve on the editorial board

Introducing DOC CARE | Journals Gateway | American Diabetes Association Introducing: Diabetes, Obesity, and Cardiometabolic CARE A New Journal for the Interdisciplinary Health Care Team In early 2026, the American Diabetes Association (ADA) will launch a new journal designed for primary care clinici...

09/22/2025

I’m currently working on 2 textbook chapters for the Association of Diabetes Care and Education
Specialists- one on neuropathy, one on retinopathy and other diabetes eye diseases. Publication will be in 2026.

09/18/2025

Orforglipron tops semaglutide in head to head trial

The ACHIEVE-3 trial was a 52-week, randomized, open-label study that included 1698 T2D patients inadequately controlled on metformin.

08/26/2025

New oral GLP-1 performs well in recent trial

The ATTAIN-2 trial evaluated the efficacy and safety of orforglipron in adults with a BMI of greater than or equal to 27kg/m2 and type 2 diabetes.

07/23/2025

https://www.medscape.com/viewarticle/tirzepatide-tops-trt-men-hypogonadism-and-obesity-2025a1000jga?ecd=wnl_edit_tpal_etid7590494&uac=82241SY&impID=7590494

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile dysfunction than those treated with testosterone.

07/23/2025

Many of you will remember Dr George M Johnson, he passed away at the age of 90 in Fargo. He was a tremendous mentor to me in my early career, he got me involved with ADA.
Outstanding physician, he will be missed.

07/22/2025

I have been asked to serve in the inaugural editorial board for the American Diabetes Associations new journal Diabetes, Obesity, and Cardiometabolic Care, beginning publication in 2026. It’s an honor to be chosen.

07/19/2025

Today is my 36th diaversery for my diagnosis of type 1 diabetes. I was a brand new doctor, just starting residency in Fargo. What a weird wild day that was. The UND School of Medicine & Health Sciences
and Altru Health System have treated me great throughout.

Things were different then- meters were large and bulky with accuracy problems, and you took 2 set doses of NPH and Regular insulin via syringe and vial daily-both poor quality insulins. I’m lucky to have lived this long to see the miracle of modern technology. I have indeed lived longer than expected for someone diagnosed in the 80’s.

Of course, it’s not always smooth sailing, but most of my days are great. If you’re struggling with type 1 diabetes, be sure to tap into your support system. I don’t use the “battle mentality”, that’s exhausting; my mindset is that I am smarter than type 1 and I stay vigilant. Thanks to all who help me along the way.

07/15/2025

Vertex stem cell derived islet cells successful at 1 year mark

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...